U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT07508046) titled 'Clinical Study on the Expression of PHGDH and Its Prognostic Value in Colorectal Cancer Patients Receiving Immunotherapy' on March 27.
Brief Summary: This study aims to evaluate the expression characteristics of PHGDH in tumor tissues based on the clinical data and pathological tissue samples of colorectal cancer patients who have previously received immunotherapy, and to analyze its correlation with patients' clinical features, immunotherapy efficacy, and survival prognosis, providing a basis for clarifying the clinical relevance of PHGDH.
Study Start Date: Nov. 01, 2025
Study Type: OBSERVATIONAL
Condition:
Colo-rectal Cancer
...